Gina Tomaine

News

Combined Low-Dose Ruxolitinib and Emapalumab Treatment Demonstrates Efficacy for Patients With Hemophagocytic Lymphohistiocytosis

07/23/2024

Gina Tomaine ;

The combination of low-dose ruxolitinib and anti-interferon-gamma antibody emapalumab demonstrated efficacy and safety for treating patients with hemophagocytic lymphohistiocytosis, according to a retrospective analysis.

The combination of low-dose...

07/23/2024

Oncology

News

Analyzing Real-World Outcomes of Emapalumab Treatment for Patients With Primary Hemophagocytic Lymphohistiocytosis

07/23/2024

Gina Tomaine ;

According to retrospective study REAL-HLH, the real-world clinical efficacy, patterns, and survival outcomes of emapalumab treatment among patients with primary hemophagocytic lymphohistiocytosis were consistent with the results a pivotal...

According to retrospective study...

07/23/2024

Oncology